Oragenics Inc. (OGEN)
NYSE · Healthcare
Oragenics Inc. Shareholder Equity 2010–2023
Oragenics Inc. annual shareholder equity history from 2010 to 2023. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Oragenics Inc. shareholder equity as of December 31, 2023: 3.2M, a 75.65% decrease year-over-year.
- Oragenics Inc. shareholder equity for 2023 were 3.2M, a 75.65% decrease from 2022.
- Oragenics Inc. shareholder equity for 2022 were 13.0M, a 50.88% decrease from 2021.
- Oragenics Inc. shareholder equity for 2021 were 26.5M, a 319.33% increase from 2017.
- Oragenics Inc. shareholder equity for 2017 were 6.3M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Oragenics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2023 | $3 |
| 2022 | $13 |
| 2021 | $26 |
| 2017 | $6 |
| 2016 | $3 |
| 2015 | $5 |
| 2014 | $10 |
| 2013 | $16 |
| 2012 | $9 |
| 2011 | $-8 |
| 2010 | $-2 |
Oragenics Inc. Shareholder Equity — FAQ
Oragenics Inc. (OGEN) shareholder equity over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see OGEN's shareholder equity history?
The chart and table above show Oragenics Inc.'s shareholder equity by year and by quarter, including the growth rate.